LifeSciencesNY, a trade group based in Central New York, urges state legislators to fund this effort in the upcoming state ...

Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...

In 2024, the software firm terminated 14% of its workforce.

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

From the Capital of France to the Capital of New York -- a cutting-edge biotech firm that uses AI to research cancer ...

After receiving a drug rejection from the FDA, Woburn-based Replimune Group (Nasdaq: REPL) has informed the state that it ...

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that ...

The full picture of Replimune's layoffs is coming into focus — and more employees are on the chopping block than previously ...

Massachusetts biotech Replimune laid off more than 200 employees Friday after the Food and Drug Administration doubled down ...

City’s largest biotech employer has cut more than 1,000 jobs in the last two years and is consolidating offices around the ...

Dozens of Massachusetts workers are about to lose their jobs after the FDA rejected a promising cancer drug — for the second ...

Gossamer Bio is picking up the pieces after failing to bring its only late-stage drug to market. The local biotech plans to ...